The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
The Journal of Immunology, 2004, 172: 4659-4660.
Copyright © 2004 by The American Association of Immunologists

IN THIS ISSUE

DC-NK interactions in tumor therapy


Chen et al. previously showed that a combination of IL-12 gene therapy (Adv.IL-12) and systemic delivery of an agonistic Ab against the costimulatory molecule, 4-1BB, was successful in treating murine metastatic colon carcinomas. In work from that same laboratory, Pan et al. (p. 4779 ) found that tumor infiltrating leukocytes (TIL) from mice treated with Adv.IL-12 plus anti-4-1BB Ab had greater ex vivo cytolytic activity against tumor cells and had more NK cells and mature dendritic cells (DC) than TIL from animals treated with either reagent alone. Mice treated with anti-NK Ab before combination therapy had large tumors, unreactive CTL, and lower serum levels of IFN-{gamma}. Only TIL from the Adv.IL-12 plus anti-4-1BB Ab-treated mice stimulated Ag-specific T cell proliferation in vitro; this activity was lost after DC depletion of the TIL. Combination-treated mice previously given anti-NK or anti-IFN-{gamma} Ab had fewer DC, and anti-IFN-{gamma} Ab reduced the enhanced expression of 4-1BB on mature DC seen in tumor bearing mice treated with Adv.IL-12. More i.v. injected fluorescent-labeled hemopoietic stem cells migrated into the tumors and matured into DC in combination-treated mice vs controls. In vitro, DC cocultured with syngeneic tumor cells expressing a 4-1BB ligand secreted more IL-12 than DC cultured with control cells, and addition of IFN-{gamma} enhanced IL-12 levels. The authors suggest that NK cells, activated by Adv.IL-12, produce IFN-{gamma} that regulates 4-1BB expression by DC that, in turn, are activated by agonistic anti-4-1BB Abs administered in the combination therapy.

T cells regulate DC maturation

Both CD4+CD25+ T cells and the maturation of dendritic cells (DC) have important roles in modulating T cell responses. However, contact-dependent interactions between CD4+CD25+ T cells and DC have not been explored. Misra et al. (p. 4676 ) found that autologous DC, matured in vitro in the presence of GM-CSF and IL-4, had significantly reduced levels of costimulatory molecules CD86, CD80, and CD40 when cocultivated with CD4+CD25+ T cells compared with DC cocultured with CD4+CD25 T cells or with DC cultured in medium with or without cytokines. Down-regulation of the costimulatory molecules was lost when the DC and T cells were separated by 0.4 µm membranes. In addition, DC cocultured with CD4+CD25+ T cells had a 3-fold reduction in stimulation of allogeneic T cells and a significant reduction in proliferation compared with the controls. Anti-TGF-{beta} mAb reversed the suppression by a modest 10%. Production of IL-10 from DC cocultured with CD4+CD25+ T cells was increased 2-fold over that seen in DC cocultured with CD4+CD25 T cells. The data show that CD4+CD25 T cells up-regulate, whereas CD4+CD25+ T cells down-regulate, DC maturation and Ag presentation.

Chimerism and autoimmunity

Following up on their previous finding of increased maternal microchimerism in patients with the multisystem autoimmune disease, juvenile dermatomyositis (JDM), Reed et al. (p. 5041 ) looked at the HLA genotypes of the mother and child and at the immunologic reactivity of the chimeric cells. Among JDM families, a sensitive PCR-based assay determined that 28 of 33 (85%) patients were chimeric for maternal cells compared with 11 of 48 (23%) of their healthy siblings. All of the healthy siblings either inherited an HLA-DQA1*0501 allele or had HLA-DQA1*0501 chimeric cells. Maternal cells were detected by fluorescent in situ hybridization in PBMCs from 22 of 30 (73%) JDM male patients compared with 12 of 39 (31%) of their healthy brothers and 5 of 29 (17%) unrelated healthy male controls. Maternal cells also were detected in affected muscle tissue in 16 of 20 (80%) JDM children compared with 2 of 10 (20%) unrelated controls. Chimeric cells isolated from JDM patients had increased frequencies of IFN-{gamma}-secreting T cells after stimulation with PBMCs from a variety of sources, but the highest levels of IFN-{gamma} transcription were seen when JDM cells were used as stimulators. The authors conclude that the presence of the DQA1*0501 allele on the maternal cells facilitates their traffic into the child, and that the reactivity of the maternal cells contributes to JDM.

FLIPping to Th2


The death receptor blocker, c-FLIPL, (cellular FLIP long form) is known to influence TCR-mediated activation of signaling pathways. Wu et al. (p. 4724 ) found that memory and naive CD4+ T cells from mice transgenic for c-FLIPL (c-FLIPL-Tg) produced higher levels of Th2 cytokines and a lower level of IFN-{gamma} after CD3/CD28 stimulation in vitro than stimulated memory or naive CD4+ T cells from nontransgenic mice. Addition of anti-IL-4 mAb to the cultures before stimulation decreased Th2 cytokine levels and increased IFN-{gamma} production, whereas addition of IFN-{gamma} had no effect. Transcription factor AP-1 binding to its DNA consensus sequence was stronger and AP-1 transcription was higher in transgenic cells by day 3 after TCR activation. TCR activation also resulted in phosphorylation of extracellular-regulated kinase, slightly decreased NF-{kappa}B binding, less phosphorylation of I{kappa}B{alpha}, higher expression of GATA-3, and lower expression of T-bet in the transgenic cells. In vivo, c-FLIPL-Tg mice had increased serum IgG1 and IgE levels and developed airway inflammation with eosinophil infiltration and mucus overproduction after OVA sensitization and challenge. The data suggest that the Th2 bias is intrinsic to the c-FLIPL-Tg CD4+ T cells and is a result of impaired NF-{kappa}B activation and up-regulated GATA-3 levels.

TLR5 on intestinal mucosa


Although the intestinal epithelium acts as a barrier to many pathogens, some bacteria are capable of translocating to the mucosal and submucosal layers. The mechanism by which mucosal cells protect the host against bacterial invasion is elucidated by Maaser et al. (p. 5056 ). Human intestinal epithelial cells grown as polarized monolayers on cell culture inserts were infected with Salmonella. After the extracellular bacteria were killed, the inserts were cocultured with endothelial cells leading to increased surface expression of ICAM-1 on the endothelial cells. LPS from the same Salmonella strain was unable to induce ICAM-1 expression. High constitutive levels of Toll-like receptor 5 (TLR5) mRNA and membrane-associated protein were found in human endothelial cell lines, in primary cultures of colonic mucosa and, by immunohistochemistry, in normal human colon. Stimulation of cultured endothelial cells with flagellin-containing fractions of Escherichia coli and Salmonella strains for 16 h resulted in up-regulation of ICAM-1 compared with unstimulated or IgG-treated cells; the flagellin-containing fractions also increased transendothelial migration of monocytes in transmigration assays. The authors suggest that TLR5 molecules on human intestinal microvascular endothelial cells serve as a second line of defense against flagellated bacteria that traverse damaged epithelia.

Migration patterns of CD8+ T cells

Tissue-specific homing patterns of lymphocytes are important in host reactions to pathogens and transplants, as well as in treatments aimed at resolving infections and eradicating tumors. Masopust et al. (p. 4875 ) found viral Ag-specific CD8+ T cells in spleen, lung, liver, small intestine, and other locations in mice infected 7 days earlier with a gut-restricted rotavirus or 9 days earlier with lung-tropic Sendai virus. Widespread dissemination also was seen for memory CD8+ T cells recovered from mice infected 34 and 64 days earlier with Sendai virus; however, there was enrichment of memory cells in lung-draining mediastinal lymph nodes. Local T cell activation in the absence of infection was achieved by adoptive transfer of OVA-reactive cells into transgenic mice that expressed OVA in the small intestine. OVA-reactive CD8+ T cells were found 5 days after transfer in all tissues examined. Virus-specific memory cells transferred into naive recipients migrated to all organs examined except the intestinal lamina propria and had a preference for the organ from which they were isolated. Memory cells from spleen, liver, and lung lacked CD69 and {beta}7 integrin expression, whereas those from intestinal mucosa were CD69+ and {beta}7 integrin+. Spleen, liver, and lung memory cells transferred into naive mice were induced to express high levels of {beta}7 integrin by virus rechallenge. The authors conclude that activated CD8+ T cells undergo widespread migration regardless of the site of Ag encounter.

WSX-1 in Leishmania infections

The structural and functional homologies of the class I cytokine receptor WSX-1 with the IL-12 receptor suggest that WSX-1 plays a role in differentiation of CD4+ Th1 cells. However, Th1 cell development and IFN-{gamma} production in WSX-1−/− mice vary with the pathogen. Artis et al. (p. 4672 ) found that WSX-1−/− mice were highly susceptible to infection with the parasite, Leishmania major, during the first 6 wk postinfection (p.i.) compared with infected wild-type controls, but they eventually controlled parasite replication and resolved their cutaneous lesions. Lymph node cells from both wild-type and WSX-1−/− mice produced high levels of IL-4 by 4 days p.i.; those levels were maintained for at least 2 wk only in the WSX-1−/− mice. By 6 wk p.i., cells from both mice released equivalent levels of Ag-specific IFN-{gamma}. Lymphocytes from WSX-1−/− mice stimulated with {alpha}CD3/{alpha}CD28 in the presence of IL-12 and anti-IL-4 mAb had a 47% increase in CD4+ T cells producing IFN-{gamma} vs treatment with control Ab. Lymph node cultures from WSX-1−/− mice treated with anti-IL-4 mAb for 4 wk p.i. produced more IFN-{gamma} and had enhanced IL-12 responses compared with untreated controls; anti-IL-4 mAb-treated animals contained their parasite infections. The data indicate that WSX-1 acts to induce IFN-{gamma} production early in an infection when IL-4 production is maximal, but it is not necessary in infections lacking a significant IL-4 response.

Phagocytosing apoptotic B cells


Two-thirds of B lineage cells in the bone marrow undergo nonproductive Ig H chain rearrangements and are removed by apoptosis. Although it is known that macrophages participate in the apoptotic process, the specific receptors and mechanism involved are unknown. Dogusan et al. (p. 4717 ) established an in vitro system in which GM-CSF-matured macrophages were cocultured with CD45R+ cells that had been treated with corticosteroids to induce apoptosis. More than 80% of the B lymphocytes that had been labeled with a dye specific for cells undergoing apoptosis associated with macrophages, compared with <50% of the nonlabeled cells. Pretreatment of macrophages with ligands for the class A scavenger receptor (SR-A), anti-CD14 Ab, or an integrin-specific tetrapeptide inhibited binding of apoptotic lymphocytes by 40–50%, 25%, and 35%, respectively; treatment of apoptotic lymphocytes with anti-CD31 Ab inhibited their phagocytosis by 25%. Confocal microscopy showed that a stromal cell line expressing CD14 and integrins, but not SR-1 or CD31, phagocytosed the apoptotic B cells; however, pretreatment of the stromal cells with the integrin-specific tetrapeptide, but not with anti-CD14 Ab, inhibited binding of the B cells. The results indicate that bone marrow macrophages use several receptors, including those for CD14, integrin, and SR-A, to identify apoptotic cells for removal, whereas bone marrow stromal cells use an integrin-dependent mechanism.

Summaries written by Dorothy L. Buchhagen, Ph.D.


Related articles in The JI:

Cutting Edge: Early IL-4 Production Governs the Requirement for IL-27-WSX-1 Signaling in the Development of Protective Th1 Cytokine Responses following Leishmania major Infection
David Artis, Leanne M. Johnson, Karen Joyce, Christiaan Saris, Alejandro Villarino, Christopher A. Hunter, and Phillip Scott
The JI 2004 172: 4672-4675. [Abstract] [Full Text]  

Cutting Edge: Human CD4+CD25+ T Cells Restrain the Maturation and Antigen-Presenting Function of Dendritic Cells
Namita Misra, Jagadeesh Bayry, Sébastien Lacroix-Desmazes, Michel D. Kazatchkine, and Srini V. Kaveri
The JI 2004 172: 4676-4680. [Abstract] [Full Text]  

Macrophages and Stromal Cells Phagocytose Apoptotic Bone Marrow-Derived B Lineage Cells
Zeynep Dogusan, Encarnacion Montecino-Rodriguez, and Kenneth Dorshkind
The JI 2004 172: 4717-4723. [Abstract] [Full Text]  

Cellular FLIP Long Form-Transgenic Mice Manifest a Th2 Cytokine Bias and Enhanced Allergic Airway Inflammation
Wenfang Wu, Lisa Rinaldi, Karen A. Fortner, Jennifer Q. Russell, Jürg Tschopp, Charles Irvin, and Ralph C. Budd
The JI 2004 172: 4724-4732. [Abstract] [Full Text]  

Regulation of Dendritic Cell Function by NK Cells: Mechanisms Underlying the Synergism in the Combination Therapy of IL-12 and 4-1BB Activation
Ping-Ying Pan, Peidi Gu, Qingsheng Li, Dongping Xu, Kaare Weber, and Shu-Hsia Chen
The JI 2004 172: 4779-4789. [Abstract] [Full Text]  

Activated Primary and Memory CD8 T Cells Migrate to Nonlymphoid Tissues Regardless of Site of Activation or Tissue of Origin
David Masopust, Vaiva Vezys, Edward J. Usherwood, Linda S. Cauley, Sara Olson, Amanda L. Marzo, Richard L. Ward, David L. Woodland, and Leo Lefrançois
The JI 2004 172: 4875-4882. [Abstract] [Full Text]  

Does HLA-Dependent Chimerism Underlie the Pathogenesis of Juvenile Dermatomyositis?
Ann M. Reed, Kelly McNallan, Peter Wettstein, Richard Vehe, and Carole Ober
The JI 2004 172: 5041-5046. [Abstract] [Full Text]  

Human Intestinal Microvascular Endothelial Cells Express Toll-Like Receptor 5: A Binding Partner for Bacterial Flagellin
Christian Maaser, Jan Heidemann, Christof von Eiff, Andreas Lugering, Thomas W. Spahn, David G. Binion, Wolfram Domschke, Norbert Lugering, and Torsten Kucharzik
The JI 2004 172: 5056-5062. [Abstract] [Full Text]  




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS